Literature DB >> 23661802

Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Sandra Waaijenborg1, Susan J M Hahné, Liesbeth Mollema, Gaby P Smits, Guy A M Berbers, Fiona R M van der Klis, Hester E de Melker, Jacco Wallinga.   

Abstract

BACKGROUND: The combined measles, mumps, and rubella (MMR) vaccine has been successfully administered for >20 years. Because of this, protection by maternal antibodies in infants born to vaccinated mothers might be negatively affected.
METHODS: A large cross-sectional serologic survey was conducted in the Netherlands during 2006-2007. We compared the kinetics of antibody concentrations in children and women of childbearing age in the highly vaccinated general population with those in orthodox Protestant communities that were exposed to outbreaks.
RESULTS: The estimated duration of protection by maternal antibodies among infants in the general population, most of whom were born to vaccinated mothers, was short: 3.3 months for measles, 2.7 months for mumps, 3.9 months for rubella, and 3.4 months for varicella. The duration of protection against measles was 2 months longer for infants born in the orthodox communities, most of whom had unvaccinated mothers. For rubella, mothers in the orthodox communities had higher concentrations of antibodies as compared to the general population.
CONCLUSION: Children of mothers vaccinated against measles and, possibly, rubella have lower concentrations of maternal antibodies and lose protection by maternal antibodies at an earlier age than children of mothers in communities that oppose vaccination. This increases the risk of disease transmission in highly vaccinated populations.

Entities:  

Keywords:  MMR vaccination; maternal antibodies; waning

Mesh:

Substances:

Year:  2013        PMID: 23661802      PMCID: PMC4043230          DOI: 10.1093/infdis/jit143

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  MMR vaccination and disease elimination: the Finnish experience.

Authors:  Irja Davidkin; Mia Kontio; Mikko Paunio; Heikki Peltola
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

2.  Negative controls: a tool for detecting confounding and bias in observational studies.

Authors:  Marc Lipsitch; Eric Tchetgen Tchetgen; Ted Cohen
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

3.  Measles in Europe: an epidemiological assessment.

Authors:  Mark Muscat; Henrik Bang; Jan Wohlfahrt; Steffen Glismann; Kåre Mølbak
Journal:  Lancet       Date:  2009-01-07       Impact factor: 79.321

4.  Mumps in a community with low vaccination coverage in the Netherlands.

Authors:  I Karagiannis; A van Lier; R van Binnendijk; Helma Ruijs; H Ruijs; E Fanoy; M A E Conyn-Van Spaendonck; H de Melker; S Hahné
Journal:  Euro Surveill       Date:  2008-06-12

5.  Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.

Authors:  E Leuridan; N Hens; V Hutse; M Ieven; M Aerts; P Van Damme
Journal:  BMJ       Date:  2010-05-18

Review 6.  Transplacental transport of IgG antibodies to preterm infants: a review of the literature.

Authors:  J P van den Berg; E A M Westerbeek; F R M van der Klis; G A M Berbers; R M van Elburg
Journal:  Early Hum Dev       Date:  2010-11-30       Impact factor: 2.079

7.  Kinetics of maternal antibodies against rubella and varicella in infants.

Authors:  E Leuridan; N Hens; V Hutse; M Aerts; P Van Damme
Journal:  Vaccine       Date:  2010-06-15       Impact factor: 3.641

8.  Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.

Authors:  Susan Hahné; Jeannette Macey; Rob van Binnendijk; Robert Kohl; Sharon Dolman; Ytje van der Veen; Graham Tipples; Helma Ruijs; Tony Mazzulli; Aura Timen; Anton van Loon; Hester de Melker
Journal:  Pediatr Infect Dis J       Date:  2009-09       Impact factor: 2.129

9.  Second national serum bank for population-based seroprevalence studies in the Netherlands.

Authors:  F R M van der Klis; L Mollema; G A M Berbers; H E de Melker; R A Coutinho
Journal:  Neth J Med       Date:  2009 Jul-Aug       Impact factor: 1.422

10.  Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Koos van der Velden; Sjoerd de Vos; Hans Knippenberg; Marlies E J L Hulscher
Journal:  BMC Public Health       Date:  2011-02-14       Impact factor: 3.295

View more
  49 in total

1.  Evaluation of the Protection Provided by Hepatitis B Vaccination in India.

Authors:  Jacob Puliyel; Pathik Naik; Ashish Puliyel; Kishore Agarwal; Vandana Lal; Nimmi Kansal; Devki Nandan; Vikas Tripathi; Prashant Tyagi; Saroj K Singh; Rajeev Srivastava; Utkarsh Sharma; V Sreenivas
Journal:  Indian J Pediatr       Date:  2018-01-10       Impact factor: 1.967

2.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

3.  Reiteration of the elimination status of measles in the southeast of Iran, 2015.

Authors:  Shahrokh Izadi; Masoome Arabsalmani; Mahdi Mohammadi; Seyed Mehdi Tabatabaei; Ali-Akbar Haghdoost
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

4.  Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey.

Authors:  Fırat Begde; Filiz Simsek Orhon; Devran Gerceker; Betul Ulukol; Seda Topcu; Sevgi Baskan
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

5.  JC virus infection is acquired very early in life: evidence from a longitudinal serological study.

Authors:  Francesca Elia; Sonia Villani; Federico Ambrogi; Lucia Signorini; Simone Dallari; Sandro Binda; Valeria Primache; Laura Pellegrinelli; Pasquale Ferrante; Serena Delbue
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

7.  Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth.

Authors:  Ronald S Veazey; Chanjuan Shen; Huanbin Xu; David Liu; Xiaolei Wang
Journal:  Vaccine       Date:  2014-08-01       Impact factor: 3.641

Review 8.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

Review 9.  Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.

Authors:  Bingyi Yang; Peng Wu; Joseph T Wu; Eric H Y Lau; Gabriel M Leung; Hongjie Yu; Benjamin J Cowling
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

10.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.